Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI

Anita Brandstäter, Stefan Kiechl, Barbara Kollerits, Steven Hunt, Iris M. Heid, Stefan Coassin, Johann Willeit, Ted D. Adams, Thomas Illig, Paul N. Hopkins, Florian Kronenberg

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

OBJECTIVE - High serum uric acid levels lead to gout and have been reported to be associated with an increased risk of hypertension, obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Recently, the putative fructose transporter SLC2A9 was reported to influence uric acid levels. The aim of the present study was to examine the association of four single nucleotide polymorphisms within this gene with uric acid levels and to determine whether this association is modified by obesity. RESEARCH DESIGN AND METHODS - Four single nucleotide polymorphisms within SLC2A9 (rs6855911, rs7442295, rs6449213, and rs12510549) were genotyped in the population-based prospective Bruneck Study (n = 800) and in a case-control study from Utah including 1,038 subjects recruited for severe obesity and 831 control subjects. RESULTS - We observed highly significant associations between all four polymorphisms and uric acid levels in all study groups. Each copy of the minor allele decreased age- and sex-adjusted uric acid levels by 0.30-0.35 mg/dl on average, which translates to a relative decrease of 5-6% with P values ranging from 10 -9 to 10 -11 in the combined analysis. An extended adjustment for BMI, creatinine, gout medication, and alcohol intake improved P values to a range of 10 -14 to 10 -20. The association was more pronounced in women and the population-based Bruneck Study and was significantly modified by BMI, with stronger effect sizes in individuals with high BMI. CONCLUSIONS - Genetic variants within SLC2A9 have significant effects on uric acid levels and are modified by sex and BMI.

Original languageEnglish
Pages (from-to)1662-1667
Number of pages6
JournalDiabetes Care
Volume31
Issue number8
DOIs
Publication statusPublished - Aug 2008
Externally publishedYes

Fingerprint

Fructose
Uric Acid
Gout
Single Nucleotide Polymorphism
Obesity
Morbid Obesity
Type 2 Diabetes Mellitus
Population
Case-Control Studies
Creatinine
Research Design
Cardiovascular Diseases
Alleles
Alcohols
Prospective Studies
Hypertension
Serum
Genes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialised Nursing

Cite this

Brandstäter, A., Kiechl, S., Kollerits, B., Hunt, S., Heid, I. M., Coassin, S., ... Kronenberg, F. (2008). Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care, 31(8), 1662-1667. https://doi.org/10.2337/dc08-0349

Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. / Brandstäter, Anita; Kiechl, Stefan; Kollerits, Barbara; Hunt, Steven; Heid, Iris M.; Coassin, Stefan; Willeit, Johann; Adams, Ted D.; Illig, Thomas; Hopkins, Paul N.; Kronenberg, Florian.

In: Diabetes Care, Vol. 31, No. 8, 08.2008, p. 1662-1667.

Research output: Contribution to journalArticle

Brandstäter, A, Kiechl, S, Kollerits, B, Hunt, S, Heid, IM, Coassin, S, Willeit, J, Adams, TD, Illig, T, Hopkins, PN & Kronenberg, F 2008, 'Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI', Diabetes Care, vol. 31, no. 8, pp. 1662-1667. https://doi.org/10.2337/dc08-0349
Brandstäter, Anita ; Kiechl, Stefan ; Kollerits, Barbara ; Hunt, Steven ; Heid, Iris M. ; Coassin, Stefan ; Willeit, Johann ; Adams, Ted D. ; Illig, Thomas ; Hopkins, Paul N. ; Kronenberg, Florian. / Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. In: Diabetes Care. 2008 ; Vol. 31, No. 8. pp. 1662-1667.
@article{c980715c719d481cb8ec7666d12151ed,
title = "Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI",
abstract = "OBJECTIVE - High serum uric acid levels lead to gout and have been reported to be associated with an increased risk of hypertension, obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Recently, the putative fructose transporter SLC2A9 was reported to influence uric acid levels. The aim of the present study was to examine the association of four single nucleotide polymorphisms within this gene with uric acid levels and to determine whether this association is modified by obesity. RESEARCH DESIGN AND METHODS - Four single nucleotide polymorphisms within SLC2A9 (rs6855911, rs7442295, rs6449213, and rs12510549) were genotyped in the population-based prospective Bruneck Study (n = 800) and in a case-control study from Utah including 1,038 subjects recruited for severe obesity and 831 control subjects. RESULTS - We observed highly significant associations between all four polymorphisms and uric acid levels in all study groups. Each copy of the minor allele decreased age- and sex-adjusted uric acid levels by 0.30-0.35 mg/dl on average, which translates to a relative decrease of 5-6{\%} with P values ranging from 10 -9 to 10 -11 in the combined analysis. An extended adjustment for BMI, creatinine, gout medication, and alcohol intake improved P values to a range of 10 -14 to 10 -20. The association was more pronounced in women and the population-based Bruneck Study and was significantly modified by BMI, with stronger effect sizes in individuals with high BMI. CONCLUSIONS - Genetic variants within SLC2A9 have significant effects on uric acid levels and are modified by sex and BMI.",
author = "Anita Brandst{\"a}ter and Stefan Kiechl and Barbara Kollerits and Steven Hunt and Heid, {Iris M.} and Stefan Coassin and Johann Willeit and Adams, {Ted D.} and Thomas Illig and Hopkins, {Paul N.} and Florian Kronenberg",
year = "2008",
month = "8",
doi = "10.2337/dc08-0349",
language = "English",
volume = "31",
pages = "1662--1667",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "8",

}

TY - JOUR

T1 - Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI

AU - Brandstäter, Anita

AU - Kiechl, Stefan

AU - Kollerits, Barbara

AU - Hunt, Steven

AU - Heid, Iris M.

AU - Coassin, Stefan

AU - Willeit, Johann

AU - Adams, Ted D.

AU - Illig, Thomas

AU - Hopkins, Paul N.

AU - Kronenberg, Florian

PY - 2008/8

Y1 - 2008/8

N2 - OBJECTIVE - High serum uric acid levels lead to gout and have been reported to be associated with an increased risk of hypertension, obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Recently, the putative fructose transporter SLC2A9 was reported to influence uric acid levels. The aim of the present study was to examine the association of four single nucleotide polymorphisms within this gene with uric acid levels and to determine whether this association is modified by obesity. RESEARCH DESIGN AND METHODS - Four single nucleotide polymorphisms within SLC2A9 (rs6855911, rs7442295, rs6449213, and rs12510549) were genotyped in the population-based prospective Bruneck Study (n = 800) and in a case-control study from Utah including 1,038 subjects recruited for severe obesity and 831 control subjects. RESULTS - We observed highly significant associations between all four polymorphisms and uric acid levels in all study groups. Each copy of the minor allele decreased age- and sex-adjusted uric acid levels by 0.30-0.35 mg/dl on average, which translates to a relative decrease of 5-6% with P values ranging from 10 -9 to 10 -11 in the combined analysis. An extended adjustment for BMI, creatinine, gout medication, and alcohol intake improved P values to a range of 10 -14 to 10 -20. The association was more pronounced in women and the population-based Bruneck Study and was significantly modified by BMI, with stronger effect sizes in individuals with high BMI. CONCLUSIONS - Genetic variants within SLC2A9 have significant effects on uric acid levels and are modified by sex and BMI.

AB - OBJECTIVE - High serum uric acid levels lead to gout and have been reported to be associated with an increased risk of hypertension, obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Recently, the putative fructose transporter SLC2A9 was reported to influence uric acid levels. The aim of the present study was to examine the association of four single nucleotide polymorphisms within this gene with uric acid levels and to determine whether this association is modified by obesity. RESEARCH DESIGN AND METHODS - Four single nucleotide polymorphisms within SLC2A9 (rs6855911, rs7442295, rs6449213, and rs12510549) were genotyped in the population-based prospective Bruneck Study (n = 800) and in a case-control study from Utah including 1,038 subjects recruited for severe obesity and 831 control subjects. RESULTS - We observed highly significant associations between all four polymorphisms and uric acid levels in all study groups. Each copy of the minor allele decreased age- and sex-adjusted uric acid levels by 0.30-0.35 mg/dl on average, which translates to a relative decrease of 5-6% with P values ranging from 10 -9 to 10 -11 in the combined analysis. An extended adjustment for BMI, creatinine, gout medication, and alcohol intake improved P values to a range of 10 -14 to 10 -20. The association was more pronounced in women and the population-based Bruneck Study and was significantly modified by BMI, with stronger effect sizes in individuals with high BMI. CONCLUSIONS - Genetic variants within SLC2A9 have significant effects on uric acid levels and are modified by sex and BMI.

UR - http://www.scopus.com/inward/record.url?scp=49649125935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49649125935&partnerID=8YFLogxK

U2 - 10.2337/dc08-0349

DO - 10.2337/dc08-0349

M3 - Article

C2 - 18487473

AN - SCOPUS:49649125935

VL - 31

SP - 1662

EP - 1667

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 8

ER -